Please login to the form below

Not currently logged in
Email:
Password:

Q4

This page shows the latest Q4 news and features for those working in and with pharma, biotech and healthcare.

Bluebird bio leans on pipeline and Zynteglo launch as revenues fall

Bluebird bio leans on pipeline and Zynteglo launch as revenues fall

Despite making headway in Europe, Zynteglo – also called LentiGlobin – is not approved in the US, and bluebird announced in its Q4 results that its marketing application to the FDA has been

Latest news

More from news
Approximately 12 fully matching, plus 114 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics